Giladi Moshe's most recent trade in NovoCure Ltd was a trade of 78,174 Stock Options (Right to buy) done . Disclosure was reported to the exchange on Feb. 27, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NovoCure Ltd | Giladi Moshe | Chief Science Officer | 27 Feb 2024 | 78,174 | 78,174 | - | - | Stock Options (Right to buy) | ||
| NovoCure Ltd | Giladi Moshe | Chief Science Officer | 27 Feb 2024 | 51,124 | 69,771 (0%) | 0% | 16.3 | 833,321 | Ordinary Shares |